ARKG holdings
ARK Genomic Revolution ETF
Positions
33 stored of 33 reported, largest first by weight
| # | Holding | ISIN | CUSIP | Weight | Value (USD) | Type | Issuer type | Country | Currency |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 10X GENOMICS INC 10X GENOMICS INC CL A COM | US88025U1097 | 88025U109 | 9.395% | $146.3M | Equity (common) | Corporate | United States | USD |
| 2 | TWIST BIOSCIENCE CORP TWIST BIOSCIENCE CORP COM | US90184D1000 | 90184D100 | 7.729% | $120.4M | Equity (common) | Corporate | United States | USD |
| 3 | TEMPUS AI INC TEMPUS AI INC CL A | US88023B1035 | 88023B103 | 6.562% | $102.2M | Equity (common) | Corporate | United States | USD |
| 4 | CRISPR THERAPEUTICS AG CRISPR THERAPEUTICS AG NAMEN AKT | CH0334081137 | Not reported | 6.285% | $97.9M | Equity (common) | Corporate | Switzerland | USD |
| 5 | PERSONALIS INC PERSONALIS INC COM | US71535D1063 | 71535D106 | 5.474% | $85.3M | Equity (common) | Corporate | United States | USD |
| 6 | ABSCI CORP ABSCI CORP COM | US00091E1091 | 00091E109 | 5.140% | $80.0M | Equity (common) | Corporate | United States | USD |
| 7 | GUARDANT HEALTH INC GUARDANT HEALTH INC COM | US40131M1099 | 40131M109 | 4.742% | $73.8M | Equity (common) | Corporate | United States | USD |
| 8 | ILLUMINA INC ILLUMINA INC COM | US4523271090 | 452327109 | 4.739% | $73.8M | Equity (common) | Corporate | United States | USD |
| 9 | ELI LILLY & COMPANY ELI LILLY & COMPANY COM | US5324571083 | 532457108 | 4.685% | $73.0M | Equity (common) | Corporate | United States | USD |
| 10 | CAREDX INC CAREDX INC COM | US14167L1035 | 14167L103 | 4.299% | $66.9M | Equity (common) | Corporate | United States | USD |
| 11 | NATERA INC NATERA INC COM | US6323071042 | 632307104 | 4.129% | $64.3M | Equity (common) | Corporate | United States | USD |
| 12 | BEAM THERAPEUTICS INC BEAM THERAPEUTICS INC COM | US07373V1052 | 07373V105 | 3.777% | $58.8M | Equity (common) | Corporate | United States | USD |
| 13 | COMPASS PATHWAYS PLC COMPASS PATHWAYS PLC SPONSORED ADS | US20451W1018 | 20451W101 | 3.254% | $50.7M | Equity (common) | Corporate | United Kingdom | USD |
| 14 | RECURSION PHARMACEUTICALS INC RECURSION PHARMACEUTICALS INC CL A | US75629V1044 | 75629V104 | 2.628% | $40.9M | Equity (common) | Corporate | United States | USD |
| 15 | ADAPTIVE BIOTECHNOLOGIES CORP ADAPTIVE BIOTECHNOLOGIES CORP COM | US00650F1093 | 00650F109 | 2.572% | $40.1M | Equity (common) | Corporate | United States | USD |
| 16 | VERACYTE INC VERACYTE INC COM | US92337F1075 | 92337F107 | 2.547% | $39.7M | Equity (common) | Corporate | United States | USD |
| 17 | NURIX THERAPEUTICS INC NURIX THERAPEUTICS INC COM | US67080M1036 | 67080M103 | 2.507% | $39.0M | Equity (common) | Corporate | United States | USD |
| 18 | BUTTERFLY NETWORK INC BUTTERFLY NETWORK INC COM CL A | US1241551027 | 124155102 | 2.178% | $33.9M | Equity (common) | Corporate | United States | USD |
| 19 | SCHRODINGER INC SCHRODINGER INC COM | US80810D1037 | 80810D103 | 1.986% | $30.9M | Equity (common) | Corporate | United States | USD |
| 20 | GENEDX HOLDINGS CORP GENEDX HOLDINGS CORP COM CL A | US81663L2007 | 81663L200 | 1.869% | $29.1M | Equity (common) | Corporate | United States | USD |
| 21 | INTELLIA THERAPEUTICS INC INTELLIA THERAPEUTICS INC COM | US45826J1051 | 45826J105 | 1.829% | $28.5M | Equity (common) | Corporate | United States | USD |
| 22 | IONIS PHARMACEUTICALS INC IONIS PHARMACEUTICALS INC COM | US4622221004 | 462222100 | 1.767% | $27.5M | Equity (common) | Corporate | United States | USD |
| 23 | ALAMAR BIOSCIENCES INC ALAMAR BIOSCIENCES INC COMMON STOCK | US0109111056 | 010911105 | 1.559% | $24.3M | Equity (common) | Corporate | United States | USD |
| 24 | PRIME MEDICINE INC PRIME MEDICINE INC COM | US74168J1016 | 74168J101 | 1.409% | $21.9M | Equity (common) | Corporate | United States | USD |
| 25 | GENERATE BIOMEDICINES INC GENERATE BIOMEDICINES INC COM SHS | US3709201004 | 370920100 | 1.113% | $17.3M | Equity (common) | Corporate | United States | USD |
| 26 | ARCTURUS THERAPEUTICS HOLDINGS INC ARCTURUS THERAPEUTICS HOLDINGS INC COM | US03969T1097 | 03969T109 | 1.014% | $15.8M | Equity (common) | Corporate | United States | USD |
| 27 | CERUS CORP CERUS CORP COM | US1570851014 | 157085101 | 0.997% | $15.5M | Equity (common) | Corporate | United States | USD |
| 28 | 908 DEVICES INC 908 DEVICES INC COM | US65443P1021 | 65443P102 | 0.980% | $15.3M | Equity (common) | Corporate | United States | USD |
| 29 | PACIFIC BIOSCIENCES OF CALIFORNIA INC PACIFIC BIOSCIENCES OF CALIFORNIA INC COM | US69404D1081 | 69404D108 | 0.956% | $14.9M | Equity (common) | Corporate | United States | USD |
| 30 | ATAIBECKLEY INC ATAIBECKLEY INC COM SHS | US04650F1012 | 04650F101 | 0.758% | $11.8M | Equity (common) | Corporate | United States | USD |
| 31 | SCRIBE THERAPEUTICS INC SCRIBE THERAPEUTICS INC COM | US8110331092 | 811033109 | 0.440% | $6.9M | Equity (common) | Corporate | United States | USD |
| 32 | QUANTUM-SI INC QUANTUM-SI INC COM CL A | US74765K1051 | 74765K105 | 0.309% | $4.8M | Equity (common) | Corporate | United States | USD |
| 33 | Goldman Sachs Financial Square Treasury Obligations Fund GOLDMAN FS TRSY OBLIG INS | Not reported | Not reported | 0.181% | $2.8M | Short-term investment vehicles (cash funds) | Registered fund | United States | USD |